April 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The biopharmaceuticals CRO market is expanding due to increasing diseases as well as rising clinical trials. North America led the market due to the presence of well-developed biopharmaceutical industries....
April 21, 2026
Projections indicate that, travel vaccination service industry is projected to rise from USD 4.69 billion in 2024 to USD 11.99 billion by 2034, reflecting a CAGR of 9.85% over the next decade. The rising prevalence of infectious disorders and increasing international travel bolster market growth. Favorable government support and a robust healthcare...
April 21, 2026
Market insights predict the global medical device CRO industry will increase from USD 8.49 billion in 2024 to USD 19.9 billion by 2034, achieving a CAGR of 8.98%.Advancements in medical technology and the increasing number of new product launches. Asia Pacific dominated the global market due to the presence of key players and increasing investments...
April 21, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
April 21, 2026
Market insights predict, the biotechnology & pharmaceutical services industry is expected to grow from USD 76.51 billion in 2024 to USD 130.56 billion by 2034, driven by a CAGR of 5.48%. Globally, accelerating technological advancements in R&D and a growing focus on personalized medicine are driving the market growth. North America do...
April 21, 2026
The advanced healthcare solutions market’s growth is attributed to the rising adoption of technology in various healthcare sectors, including therapeutics, diagnostics, patient data management, and remote patient monitoring etc. North America dominated the market due to the presence of leading healthcare service providers....
April 21, 2026
The market is expanding due to rising demand for more accurate and human-relevant testing methods in drug development. These models offer improved predictions of clinical outcomes, reducing reliance on animal testing and accelerating research efficiency. North America is dominating due to growing investments in clinical trials. ...
April 21, 2026
According to market projections, the therapeutic drug monitoring (TDM) sector is expected to grow from USD 1.92 billion in 2024 to USD 2.8 billion by 2034, reflecting a CAGR of 3.84%. Globally, the rising prevalence of chronic diseases, along with the growing adoption of technological advancements, including analytical techniques, is driving the ma...
April 21, 2026
Based on market forecasts, the global gastrointestinal drugs market, projected at USD 40.21 billion in 2024, is expected to reach USD 55.85 billion by 2034, growing at a CAGR of 3.34% over the forecast period. The gastrointestinal drugs market is growing due to these drugs are used for various treatments in people with excess stomach acid, stomach ...
April 21, 2026
According to market projections, the global scopolamine market, valued at USD 469.29 million in 2024, is anticipated to reach USD 826.19 million by 2034, growing at a CAGR of 5.79% over the next decade.The scopolamine market is growing due to it reduce the severity of nausea and vomiting in various conditions, such as motion sickness, by blocking n...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com